Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.09.2023 | Case report

Ceftriaxone

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kappler J, et al. CXCL13 and the Differential Diagnosis of Neuroborreliosis: Very High Level of CXCL13 in the Cerebrospinal Fluid in a Patient with Presumed Bing-Neel Syndrome (CNS Manifestation of Waldenstrom's Disease). Laboratoriums-Medizin: Journal of Laboratory Medicine 42: eA47 abstr. DGKL-P064, No. 4, 30 Aug 2018. Available from: URL: http://doi.org/10.1515/labmed-2018-0115 [abstract] Kappler J, et al. CXCL13 and the Differential Diagnosis of Neuroborreliosis: Very High Level of CXCL13 in the Cerebrospinal Fluid in a Patient with Presumed Bing-Neel Syndrome (CNS Manifestation of Waldenstrom's Disease). Laboratoriums-Medizin: Journal of Laboratory Medicine 42: eA47 abstr. DGKL-P064, No. 4, 30 Aug 2018. Available from: URL: http://​doi.​org/​10.​1515/​labmed-2018-0115 [abstract]
Metadaten
Titel
Ceftriaxone
Lack of efficacy: case report
Publikationsdatum
01.09.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-46829-z

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Arsenic